(Q34368055)

English

Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?

scientific article

In more languages

edit

Statements

instance of

scholarly article

1 reference

stated in

Europe PubMed Central

1 August 2017

Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization? (English)

1 reference

stated in

Europe PubMed Central

1 August 2017

0 references

Steven A Grover

1

1 reference

stated in

Europe PubMed Central

PubMed ID

15545508

retrieved

1 August 2017

Louis Coupal

series ordinal

2

1 reference

stated in

Europe PubMed Central

PubMed ID

15545508

retrieved

1 August 2017

Hanna Zowall

series ordinal

3

1 reference

stated in

Europe PubMed Central

PubMed ID

15545508

retrieved

1 August 2017

language of work or name

English

0 references

publication date

15 November 2004

1 reference

stated in

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

1 August 2017

45

1 reference

stated in

Europe PubMed Central

1 August 2017

1

1 reference

stated in

Europe PubMed Central

1 August 2017

92-97

1 reference

stated in

Europe PubMed Central

PubMed ID

15545508

retrieved

1 August 2017

Identifiers

DOI

10.1161/01.HYP.0000149684.01903.B8

1 reference

stated in

Europe PubMed Central

1 August 2017

1 reference

Europe PubMed Central

PubMed ID

15545508

retrieved

1 August 2017

ResearchGate publication ID

8180587

0 references

(Q34368055)

Treating osteoarthritis with cyclooxygenase-2-specific inhibitors: what are the benefits of avoiding blood pressure destabilization?

Statements

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)